Dobutamine: Clinical Trials

9 trials of Dobutamine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 3 unknown, 1 terminated. 9 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 39Completed 5, Unknown 3, Terminated 1
Phase 23Completed 2, Unknown 1

Follow Dobutamine: new trials by email Literature Review of Dobutamine trials Research Report on Dobutamine

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ivabradine Effects in Cardiogenic Shock Requiring Inotropic Support
Ivabradine 7.5Mg Tab, DOBUTamine Injectable Solution - Heart Failure, Cardiogenic Shock
Phase 3UnknownThe Young Investigator Group of Cardiovascular Research2002022-07-012022-10-26
Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion
Placebos, Dobutamine - Sepsis, Cardiomyopathies
Phase 3CompletedUniversity Hospital, Limoges1362020-09-202025-11-21
Norepinephrine vs Norepinephrine and Dobutamine in Cardiogenic Shock
Norepinephrine - Cardiogenic Shock
Phase 3UnknownCentral Hospital, Nancy, France402018-01-152017-11-14
Levosimendan Versus Dobutamine for Renal Function in Heart Failure
Levosimendan, Dobutamine - Cardiorenal Syndrome
Phase 3CompletedGöteborg University332014-04-012020-02-25
The Effects of Glucocorticoids on Mortality and Renal Function in Patients With Acute Decompensated Heart Failure
glucocorticoid, standard care - Heart Failure
Phase 2 / Phase 3CompletedHebei Medical University1022009-01-012012-02-22
Cardiac Function Under Stress for Early Detection of the Right Ventricular Insufficiency After Repair of Tetralogy of Fallot
Dobutamin - Tetralogy of Fallot
Phase 3TerminatedCompetence Network for Congenital Heart Defects532007-11-012012-06-06
Levosimendan Versus Dobutamine in Shock Patients
Levosimendan, Dobutamine - Cardiogenic Shock, Septic Shock
Phase 2 / Phase 3UnknownWentworth Area Health Services402004-10-012005-06-24
Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support: a Multicentre, Parallel-Group, Randomised, Double-Blind, Double-Dummy Study of Levosimendan Versus Dobutamine in Patients With Acute Heart Failure.
levosimendan, dobutamine - Acute Heart Failure
Phase 3CompletedAbbott13002003-03-012007-11-20
Norepinephrine Plus Dobutamine Versus Epinephrine Alone for the Management of Septic Shock
norepinephrine and dobutamine, epinephrine plus placebo of dobutamine - Septic Shock, Severe Sepsis
Phase 2 / Phase 3CompletedUniversity of Versailles3301999-10-012010-07-22

Conditions studied

Heart Failure (4)  ·  Sepsis (3)  ·  Shock, Cardiogenic (3)  ·  Shock (2)  ·  Shock, Septic (2)  ·  Cardio-Renal Syndrome (1)  ·  Cardiomyopathies (1)  ·  Infections (1)  ·  Myocardial Ischemia (1)  ·  Renal Insufficiency (1)  ·  Tetralogy of Fallot (1)  ·  Ventricular Dysfunction, Left (1)

Sponsors

Abbott (1)  ·  Central Hospital, Nancy, France (1)  ·  Competence Network for Congenital Heart Defects (1)  ·  Göteborg University (1)  ·  Hebei Medical University (1)  ·  The Young Investigator Group of Cardiovascular Research (1)  ·  University Hospital, Limoges (1)  ·  University of Versailles (1)  ·  Wentworth Area Health Services (1)

Countries

France (3)  ·  Australia (1)  ·  China (1)  ·  Egypt (1)  ·  Germany (1)  ·  Sweden (1)  ·  United States (1)

Top investigators

Djillali Annane, MD, PhD (1)  ·  Eric Bellissant, MD, PhD (1)  ·  Kristjan Karason, MD, PhD (1)  ·  Kunshen Liu, MD (1)  ·  Philipp Beerbaum, MD (1)  ·  Robert J Padley, M.D. (1)

Results publications

PMID 10889132, PMID 15769768, PMID 16461840, PMID 17473298, PMID 17720019, PMID 19539144, PMID 28785469, PMID 30369310, PMID 40588393

NIH funding

2017 (1)